Blood Culture Screening Devices used in Blood Culture is a microbiological Culture of Blood. It is employed to detect infections that are spreading through the bloodstream (to the as bacteremia,Sepsis amongst others). This is possible because the bloodstream is usually a sterile environment.
Due to the COVID-19 pandemic, the global Blood Culture Screening Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Blood Culture Screening Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Blood Culture Screening Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Automated Blood Culture Systems accounting for % of the Blood Culture Screening Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Blood Culture Screening Devices include bioMérieux SA, Thermofisher, Becton, Dickinson and Company, Haemonetics, Fresenius and Terumo, etc. In terms of revenue, the global 3 largest players have a % market share of Blood Culture Screening Devices in 2021.
This report focuses on Blood Culture Screening Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Blood Culture Screening Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Blood Culture Screening Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Automated Blood Culture Systems
Supporting Equipment
Segment by Application
Hospitals
Blood Banks
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
bioMérieux SA
Thermofisher
Becton, Dickinson and Company
Haemonetics
Fresenius
Terumo